- Home
- SRPT vs ICUCW Comparison
SRPT vs ICUCW Comparison
Compare SRPT & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- ICUCW
- Stock Information
- Founded
- SRPT 1980
- ICUCW N/A
- Country
- SRPT United States
- ICUCW United States
- Employees
- SRPT N/A
- ICUCW 19
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- ICUCW Health Care
- Exchange
- SRPT Nasdaq
- ICUCW Nasdaq
- Market Cap
- SRPT N/A
- ICUCW N/A
- IPO Year
- SRPT 1997
- ICUCW 2021
- Fundamental
- Price
- SRPT $17.67
- ICUCW $0.02
- Analyst Decision
- SRPT Buy
- ICUCW
- Analyst Count
- SRPT 25
- ICUCW 0
- Target Price
- SRPT $64.00
- ICUCW N/A
- AVG Volume (30 Days)
- SRPT 7.7M
- ICUCW N/A
- Earning Date
- SRPT 08-06-2025
- ICUCW N/A
- Dividend Yield
- SRPT N/A
- ICUCW N/A
- EPS Growth
- SRPT N/A
- ICUCW N/A
- EPS
- SRPT N/A
- ICUCW N/A
- Revenue
- SRPT $2,233,371,000.00
- ICUCW N/A
- Revenue This Year
- SRPT $26.87
- ICUCW N/A
- Revenue Next Year
- SRPT $3.15
- ICUCW N/A
- P/E Ratio
- SRPT N/A
- ICUCW N/A
- Revenue Growth
- SRPT 59.15
- ICUCW N/A
- 52 Week Low
- SRPT $16.88
- ICUCW N/A
- 52 Week High
- SRPT $162.95
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- SRPT 18.77
- ICUCW N/A
- Support Level
- SRPT $18.30
- ICUCW N/A
- Resistance Level
- SRPT $22.98
- ICUCW N/A
- Average True Range (ATR)
- SRPT 1.43
- ICUCW 0.00
- MACD
- SRPT -0.49
- ICUCW 0.00
- Stochastic Oscillator
- SRPT 0.99
- ICUCW 0.00
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.